Aventa™ Genomics, LLC, a clinical laboratory established as a joint venture between Arima Genomics, Inc. and Protean BioDiagnostics Inc., today announced the launch of Aventa FusionPlus, a next-generation sequencing (NGS) test for the detection of gene fusions, translocations, and rearrangements across 361 genes from formalin-fixed, paraffin embedded (FFPE) tumor tissue.
U.S. teens vaping CBD at alarming rates: Study reveals surprising factors behind trend
The recent JAMA Network Open study finds a significant prevalence of CBD vaping among U.S. adolescents, with higher rates among Hispanic and sexual minority youth.
August 31, 2023